Search clinical trials for: iTind

Total 10 results

Medi-Tate Ltd.

Active, not recruiting

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH (MT-06)

BPH

France, Italy, Germany, Australia, Spain, Switzerland
Medi-Tate Ltd.

Terminated

Study to Assess the Efficacy, Safety and Tolerability of (iTind)

BPH

United Kingdom
University of Manitoba

Not yet recruiting

Outcomes of MIST for BPH: A Single-Institution Prospective Study

Benign Prostatic Hyperplasia

Canada
Chinese University of Hong Kong

Recruiting

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

Prostate Hyperplasia

Hong Kong
Medi-Tate Ltd.

Terminated

A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI

BPH

Germany
Olympus Corporation of the Americas

Recruiting

A Randomized, International Study to Assess the Safety of iTind Compared to UroLift (MT-08)

Benign Prostatic Hyperplasia (BPH)

United States, United Kingdom, Canada
Medi-Tate Ltd.

Completed

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

Benign Prostate Hyperplasia

United States, Canada
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
Medi-Tate Ltd.

Completed

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

Benign Prostate Hyperplasia | Bladder Neck Obstruction

Israel
Yale University

Withdrawn

A New Wizard for Insulin Sensitivity Estimation From SAP: a Randomized Controlled Trial in Adolescents With T1D

Diabetes Mellitus

United States

3

Subscribe